Amgen launched its adalimumab biosimilar - Amjevita ( FDA approved in 2016), has 2 different discountsâ 55% or 5% be
Tweet Content
Amgen launched its adalimumab biosimilar - Amjevita ( FDA approved in 2016), has 2 different discounts— 55% or 5% below Humira's (list $6,922/mo). Another report says Amjevita 40mg given q 2wk will cost $40,497 - $85,494 annually https://t.co/iGtJUa991N https://t.co/PTPTUskUaa
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off